Arteris (NASDAQ:AIP) CEO Sells $2,184,000.00 in Stock

Arteris, Inc. (NASDAQ:AIPGet Free Report) CEO K Charles Janac sold 70,000 shares of the company’s stock in a transaction on Friday, May 8th. The stock was sold at an average price of $31.20, for a total value of $2,184,000.00. Following the sale, the chief executive officer owned 9,049,071 shares of the company’s stock, valued at approximately $282,331,015.20. This represents a 0.77% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

K Charles Janac also recently made the following trade(s):

  • On Wednesday, April 8th, K Charles Janac sold 70,000 shares of Arteris stock. The stock was sold at an average price of $19.04, for a total value of $1,332,800.00.
  • On Thursday, April 2nd, K Charles Janac sold 9,009 shares of Arteris stock. The stock was sold at an average price of $17.65, for a total value of $159,008.85.
  • On Monday, April 6th, K Charles Janac sold 11,800 shares of Arteris stock. The stock was sold at an average price of $18.34, for a total value of $216,412.00.
  • On Thursday, March 26th, K Charles Janac sold 32,988 shares of Arteris stock. The stock was sold at an average price of $18.35, for a total value of $605,329.80.
  • On Wednesday, March 25th, K Charles Janac sold 7,012 shares of Arteris stock. The stock was sold at an average price of $18.03, for a total value of $126,426.36.
  • On Tuesday, March 10th, K Charles Janac sold 9,000 shares of Arteris stock. The shares were sold at an average price of $14.66, for a total value of $131,940.00.
  • On Monday, March 9th, K Charles Janac sold 41,000 shares of Arteris stock. The shares were sold at an average price of $14.21, for a total value of $582,610.00.

Arteris Stock Performance

Shares of AIP opened at $37.34 on Friday. Arteris, Inc. has a 12 month low of $6.88 and a 12 month high of $38.47. The stock has a fifty day moving average price of $21.16 and a 200-day moving average price of $17.47. The company has a current ratio of 0.73, a quick ratio of 1.13 and a debt-to-equity ratio of 0.17. The firm has a market cap of $1.72 billion, a PE ratio of -47.27 and a beta of 1.93.

Arteris (NASDAQ:AIPGet Free Report) last issued its quarterly earnings data on Tuesday, May 12th. The company reported ($0.03) EPS for the quarter, beating the consensus estimate of ($0.08) by $0.05. The business had revenue of $22.94 million for the quarter, compared to analysts’ expectations of $21.03 million. Equities research analysts predict that Arteris, Inc. will post -0.68 earnings per share for the current fiscal year.

More Arteris News

Here are the key news stories impacting Arteris this week:

  • Positive Sentiment: Arteris reported a smaller-than-expected Q1 loss of $0.03 per share, ahead of estimates, while revenue of $22.94 million also topped expectations. Article Title
  • Positive Sentiment: Management lifted 2026 revenue guidance and guided Q2 sales above prior expectations, which suggests stronger demand and better execution ahead. Article Title
  • Positive Sentiment: Rosenblatt Securities sharply raised its price target on Arteris, reinforcing bullish sentiment after the earnings beat and stronger outlook. Article Title
  • Positive Sentiment: Analysts highlighted Arteris’ earnings call as evidence of surging growth and a clearer path to profitability. Article Title
  • Neutral Sentiment: The company disclosed a CFO retirement, but the market appears focused more on the strong operating results and growth outlook than on the leadership change. Article Title
  • Negative Sentiment: A new investor warning flagged Arteris as carrying high risk of significant loss and highlighted shareholder-rights concerns, which could temper enthusiasm at the margins. Article Title
  • Negative Sentiment: A major shareholder also sold 70,000 shares, which may add some caution even though the transaction was relatively small versus the holder’s total position. Article Title

Hedge Funds Weigh In On Arteris

Several hedge funds have recently made changes to their positions in the company. Needham Investment Management LLC increased its position in shares of Arteris by 2.6% in the 4th quarter. Needham Investment Management LLC now owns 3,411,500 shares of the company’s stock valued at $52,878,000 after acquiring an additional 86,500 shares during the period. Franklin Resources Inc. increased its position in shares of Arteris by 6.2% in the 4th quarter. Franklin Resources Inc. now owns 1,743,031 shares of the company’s stock valued at $27,017,000 after acquiring an additional 101,646 shares during the period. Vanguard Group Inc. increased its position in shares of Arteris by 8.2% in the 3rd quarter. Vanguard Group Inc. now owns 1,594,402 shares of the company’s stock valued at $16,103,000 after acquiring an additional 120,947 shares during the period. Westerly Capital Management LLC increased its position in shares of Arteris by 109.6% in the 3rd quarter. Westerly Capital Management LLC now owns 1,425,000 shares of the company’s stock valued at $14,392,000 after acquiring an additional 745,000 shares during the period. Finally, Goldman Sachs Group Inc. increased its position in shares of Arteris by 144.7% in the 4th quarter. Goldman Sachs Group Inc. now owns 1,012,670 shares of the company’s stock valued at $15,696,000 after acquiring an additional 598,840 shares during the period. 64.36% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several analysts have recently commented on AIP shares. Weiss Ratings lowered Arteris from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday. Rosenblatt Securities increased their price objective on Arteris from $20.00 to $38.00 and gave the company a “buy” rating in a report on Wednesday. TD Cowen increased their price objective on Arteris from $22.00 to $40.00 and gave the company a “buy” rating in a report on Wednesday. Wall Street Zen lowered Arteris from a “buy” rating to a “hold” rating in a report on Saturday, May 2nd. Finally, Northland Securities set a $38.00 price objective on Arteris in a report on Wednesday. Two analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company currently has an average rating of “Hold” and an average target price of $37.75.

Check Out Our Latest Stock Analysis on AIP

Arteris Company Profile

(Get Free Report)

Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company’s core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.

Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.

Featured Stories

Insider Buying and Selling by Quarter for Arteris (NASDAQ:AIP)

Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.